Relapsing Remitting Multiple Sclerosis and Memory The impact of Fingolomid on cognitive functioning in females between the age of 35-50 Your Name Goes Here Institutional Affiliation Goes Here Abstract Recent research of potential treatments for Multiple Sclerosis has identified two medications that present promising results in ameliorating the development of sclera: Fingolomid, and Cladribine. While initial studies have demonstrated efficacy in the stabilization and potential improvement of neurological conditions, discrete neurological functions such as memory have not been studied in connection with these medications. This study evaluates the impact of Fingolomid on memory stabilization or reversal of impairment in Severe...The end:
.....lated differences in prospective memory. . Applied Cognitive Psychology, Vol 14(SpecIssue), S43-S62. Wachowius, U., Silver, N., Heinze, H., Sailer, M., & Talley, M. (2005). Cognitive Impairment in Primary and Secondary Progressive Multiple Sclerosis . Journal of clinical and experimental neuropsychology, Volume 27,(Issue 1), 65 - 77. Wilken, J., Mandler., Kerr., Reeves, D., Fuchs, K., Manning, C., Keller, M., Kane., Sullivan., Wallin., Usiskin., Quig., Simsarian., Saunders., & Crayton. (2003). The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting multiple sclerosis.. Multiple Sclerosis, Mar(9(2)), 119-27.. (2008). Psychiatry (Psychiatry (Tasman)). New York, NY: Wiley.